Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MDK Study: Using a Combination of Methadone-dexmedetomidine-ketamine for Postoperative Pain Control in Patients Undergoing Complex Spine Surgeries.

NCT07365800 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT07365800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07365800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MDK Study: Using a Combination of Methadone-dexmedetomidine-ketamine for Postoperative Pain Control in Patients Undergoing Complex Spine Surgeries.
Lead sponsor
University of Missouri-Columbia
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
April 24, 2026
Completion date
June 30, 2027
Enrollment
248 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spine surgery